HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sensitive skin assay added to cosmetics toxicological testing recommended by Kligman.

This article was originally published in The Rose Sheet

Executive Summary

SENSITIVE SKIN SCREENING ASSAY ADDITION TO COSMETICS TOXICOLOGICAL TESTING recommended by Albert Kligman, MD/PhD, University of Pennsylvania, at International Business Communication's Novel In Vitro and Clinical Testing Methods for Skin Care and Cosmetics Products conference held Sept. 17-18 in Boston. Cosmetic manufacturers "would be well served to do some [sensitive skin testing] before [they] launch a product into a multi-million dollar consumer market," Kligman asserted, since people with sensitive skin experience burning, stinging and other adverse reactions even when products test fine on individuals with "normal" skin.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003251

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel